Comparison of the metabolic effects of sustained CCK1 receptor activation alone and in combination with upregulated leptin signalling in high-fat-fed mice

Beneficial Effects of (pGlu-Gln)-CCK-8 on Energy Intake and Metabolism in High Fat Fed Mice are Associated with Alterations of Hypothalamic Gene Expression

(2013) I. Montgomery et al.   HORMONE AND METABOLIC RESEARCH

Leptin and the central control of feeding behavior

(2012) Luc Pénicaud et al.   BIOCHIMIE

Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment

(2012) M. S. Fineman et al.   DIABETES OBESITY & METABOLISM

Beneficial effects of the novel cholecystokinin agonist (pGlu-Gln)-CCK-8 in mouse models of obesity/diabetes

(2012) N. Irwin et al.   DIABETOLOGIA

Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob/ob mice

(2012) W D Porter et al.   INTERNATIONAL JOURNAL OF OBESITY

Leptin Resistance in Vagal Afferent Neurons Inhibits Cholecystokinin Signaling and Satiation in Diet Induced Obese Rats

(2012) Guillaume de Lartigue et al.   PLoS One

Efficacy of Metreleptin in Obese Patients With Type 2 Diabetes: Cellular and Molecular Pathways Underlying Leptin Tolerance

(2011) H.-S. Moon et al.   DIABETES

CCK Stimulation of GLP-1 Neurons Involves α 1 -Adrenoceptor–Mediated Increase in Glutamatergic Synaptic Inputs

(2011) Kazunari Hisadome et al.   DIABETES

Impaired Insulin Secretion and Enhanced Insulin Sensitivity in Cholecystokinin-Deficient Mice

(2011) C.-M. Lo et al.   DIABETES

Plasticity in vagal afferent neurones during feeding and fasting: mechanisms and significance*

(2010) G. J. Dockray et al.   Acta Physiologica

Intranasal delivery of mouse [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, improves energy balance, glycaemic control, insulin sensitivity and bone formation in leptin-resistant C57BLK/6-m db/db mice

(2010) M. A. Waldrop et al.   DIABETES OBESITY & METABOLISM

Active immunization against (Pro3)GIP improves metabolic status in high-fat-fed mice

(2010) I. A. Montgomery et al.   DIABETES OBESITY & METABOLISM

EGR1Is a Target for Cooperative Interactions between Cholecystokinin and Leptin, and Inhibition by Ghrelin, in Vagal Afferent Neurons

(2010) Guillaume de Lartigue et al.   ENDOCRINOLOGY

Fatty acid derivatised analogues of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic properties

(2009) Barry D. Kerr et al.   BIOCHEMICAL PHARMACOLOGY

Cholecystokinin and gut–brain signalling

(2009) Graham J. Dockray   REGULATORY PEPTIDES

A cholecystokinin-1 receptor agonist (CCK-8) mediates increased permeability of brain barriers to leptin

(2008) V Cano et al.   BRITISH JOURNAL OF PHARMACOLOGY

Leptin-Mediated Hypothalamic Pathway of Cholecystokinin (CCK-8) to Regulate Body Weight in Free-Feeding Rats

(2007) Beatriz Merino et al.   ENDOCRINOLOGY